Amarantus and Boston University to evaluate test for early signs of neurodegenerative diseases Jan. 31, 2014 No Comments
OPS-202 receives EMA orphan drug designation for management of neuroendocrine tumors Jan. 30, 2014 No Comments
OncoCyte commences clinical development of bladder cancer diagnostics in U.S. and China Jan. 29, 2014 No Comments
MDxHealth and Teva Pharmaceuticals sign agreement to commercialize two cancer tests in Israel Jan. 24, 2014 No Comments
DiaGenic reports final results from exploratory study of blood test for Alzheimer's disease Jan. 24, 2014 No Comments
RSS